The Latest Breaking News from Pfizer

Pfizer is taking on Amgen with its next steps in weight loss, the pharma titan said Tuesday as Pfizer stock dipped despite its beat.

December S&P 500 E-Mini futures (ESZ24) are up +0.06%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.08% this morning as market participants geared up for the latest reading on U.S. job openings while also awaiting a deluge of corporate earnings reports from heavyweight names.

Pfizer is expected to release its fiscal third-quarter earnings later this month, and analysts project a triple-digit profit growth.

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

Nvidia is expected to boost the S&P 500 Q3 earnings growth rate. Meta Platforms and Alphabet may lift Communications Services earnings.

Explore why traditional value investing often falls short and how catalysts can transform undervalued stocks into lucrative investments.

The stock market had a key week, as the S&P 500 and Dow hit record highs. The Tesla robotaxi failed to wow, but many leaders broke out.

'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.